My watch list
my.bionity.com  
Login  

Induced Pluripotent Stem Cells

Companies Induced Pluripotent Stem Cells

BlueRock Therapeutics, USA

BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ CELL+GENE™ platform harnesses the power of cells for new medicines across neurology, cardiology and immunology indications. BlueRock Th more

News Induced Pluripotent Stem Cells

  • Customized programming of human stem cells

    Induced pluripotent stem cells (iPS) have the potential to convert into a wide variety of cell types and tissues. However, the "recipes" for this conversion are often complicated and difficult to implement. Researchers at the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden, Harvard Un more

  • Midbrain organoids for automated chemical screening and disease research

    Sometimes hundreds of thousands of potential therapeutics need to be tested in large-scale, fully automated experiments to identify a single effective drug. Most compounds do not work as desired, and some are even toxic. Since the development of the induced Pluripotent Stem (iPS) Cell technology in more

  • Generation of human brain organoids with the ability to learn

    The brain is one of the most complex organs in the human body. Complexity of the brain is the result of highly and dynamically interconnected neurons as well as supporting glia. Lifelong changes in neuronal interconnectivity are key for memory and learning. Disturbances in neuronal interconnectivity more

All news on induced pluripotent stem cells

Publications Induced Pluripotent Stem Cells

All publications on induced pluripotent stem cells
Related topics

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE